Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000343260

Medchemexpress LLC (SP-4-2)-diamminetrans-dioxo(tetrahydro-2H-pyran-4,4-diyl)dihydrogen phosphate platinum | 1339960-28-9 | 95.0% | 485.23 | 100 MG
SDP

Catalog No. 5000343260
Encompass_Preferred

Imifoplatin (PT-112) is a platinum-based active molecule, categorized within the phosphaplatins family. It is known for its ability to induce apoptosis and demonstrates significant antitumor activity. This compound has been investigated for its potential in treating various cancers, showing promising results in both *in vitro* and *in vivo* studies, particularly in inhibiting proliferation and inducing apoptosis in cancer cell lines.

  • Induces apoptosis.
  • Exhibits antitumor activity.
  • Shows dose-dependent proliferation inhibition in cancer cells.
  • Significantly increases mitochondrial reactive oxygen species (mtROS).
  • Demonstrates potent antitumor immune effects in xenograft models.
  • Shows synergistic antitumor effects when combined with immune checkpoint blockers.

Catalog No. 50-003-43260 Supplier Medchemexpress LLC Supplier No. HY10914610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Imifoplatin (PT-112) is a platinum-based active molecule, categorized within the phosphaplatins family. It is known for its ability to induce apoptosis and demonstrates significant antitumor activity. This compound has been investigated for its potential in treating various cancers, showing promising results in both *in vitro* and *in vivo* studies, particularly in inhibiting proliferation and inducing apoptosis in cancer cell lines.

  • Induces apoptosis.
  • Exhibits antitumor activity.
  • Shows dose-dependent proliferation inhibition in cancer cells.
  • Significantly increases mitochondrial reactive oxygen species (mtROS).
  • Demonstrates potent antitumor immune effects in xenograft models.
  • Shows synergistic antitumor effects when combined with immune checkpoint blockers.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.